A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers()

OBJECTIVES: A phase II trial designed to evaluate the safety and efficacy of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine or epithelial ovarian cancers. METHODS: Eligible patients with recurrent epithelial ovarian or uterine cancers were treated with weekly topot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gynecol Oncol
Main Authors: Gupta, Divya, Owers, Ricky L., Kim, Mimi, Kuo, Dennis Yi-Shin, Huang, Gloria S., Shahabi, Shohreh, Goldberg, Gary L., Einstein, Mark H.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451225/
https://ncbi.nlm.nih.gov/pubmed/19307014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.02.018
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares